A cosmeceutical formulation based on boswellic acids for the treatment of erythematous eczema and psoriasis

BACKGROUND: Boswellic acids (BAs) show anti-inflammatory properties in a variety of inflammatory diseases, including rheumatoid arthritis, osteoarthritis, and asthma. A topical administration route is currently used to deliver active compounds in psoriatic and eczematous patients. In this double-bli...

Descripción completa

Detalles Bibliográficos
Autores principales: Togni, Stefano, Maramaldi, Giada, Di Pierro, Francesco, Biondi, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235203/
https://www.ncbi.nlm.nih.gov/pubmed/25419153
http://dx.doi.org/10.2147/CCID.S69240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235203/
https://www.ncbi.nlm.nih.gov/pubmed/25419153
http://dx.doi.org/10.2147/CCID.S69240

Ejemplares similares